High expression of DNA repair pathways is associated with metastasis in melanoma patients
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
We have identified a gene-profile signature for human primary malignant melanoma associated with metastasis to distant sites and poor prognosis. We analyse the differential gene expression by looking at whole biological pathways rather than individual genes. Among the most significant pathways associated with progression to metastasis, we found the DNA replication (P=10(-14)) and the DNA repair pathways (P=10(-16)). We concentrated our analysis on DNA repair and found that 48 genes of this category, among a list of 234 genes, are associated with metastatic progression. These genes belong essentially to the pathways allowing recovery of stalled replication forks due to spontaneous blockage or induced DNA lesions. Because almost all these differentially expressed repair genes were overexpressed in primary tumors with bad prognosis, we speculate that primary melanoma cells that will metastasize try to replicate in a fast and error-free mode. In contrast to the progression from melanocytes to primary melanoma, genetic stability appears to be necessary for a melanoma cell to give rise to distant metastasis. This overexpression of repair genes explains nicely the extraordinary resistance of metastatic melanoma to chemo- and radio-therapy. Our results may open a new avenue for the discovery of drugs active on human metastatic melanoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, one study has found that OGG1 is overexpressed in some metastatic melanomas73.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [73]
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 2×
“The Tumor types Repair Replication Bladder (Dyrskjot et al., 2003) (27) n¼ 29 Carcinoma 6.9 10 3 NS Breast (van’t Veer et al., 2002) (28) n¼ 78 Lymph-node negative primary tumor 1.4 10 2 6.6 10 4 Breast (Wang et al., 2005) (29) n¼ 286 Lymph-node negative primary tumor 4.4 10 3 8.0 10 3 Squamous…”
MethodInfluentialA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
The epidemiology of UV induced skin cancer
Armstrong, B. K., & Kricker, A. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00198-1 · Cited by 1,811 · cited 1×
“The best evidence of a causative link with sun exposure is the association of melanoma with severe episodic sunburn in infancy (Armstrong and Kricker, 2001).”
BackgroundFoxM1 is required for execution of the mitotic programme and chromosome stability
Laoukili, J., Kooistra, M. R. H., Brás, A., Kauw, J., Kerkhoven, R. M., Morrison, A., Clevers, H., & Medema, R. H. (2005) · Nature Cell Biology · doi:10.1038/ncb1217 · Cited by 807
Control of Human Telomere Length by TRF1 and TRF2
Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., & de Lange, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1659-1668.2000 · Cited by 768 · cited 1×
“Interestingly, TERF1, specifically involved in telomere maintenance (Smogorzewska et al., 2000), is also overexpressed in Mþ tumor cells.”
BackgroundHowe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A. G., Rosenberg, H. M., Feigal, E. G., & Edwards, B. K. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.824 · Cited by 738
Cited by
Items 101–200 of 277
Tran, O., Tadesse, S., Chu, C. S., & Kidane, D. (2020) · Tumor Biology · doi:10.1177/1010428320918404 · Cited by 36
Srinivasan, A., & Gold, B. I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.58 · Cited by 36
Caporali, S., Alvino, E., Lacal, P. M., Ruffini, F., Levati, L., Bonmassar, L., Scoppola, A., Marchetti, P., Mastroeni, S., Cappellini, G. C. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23052 · Cited by 32
Valin, A., Barnay‐Verdier, S., Robert, T., Ripoche, H., Brellier, F., Chevallier, O., Avril, M., & Magnaldo, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004818 · Cited by 34
DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance
de Sousa, J. F., Serafim, R. B., de Freitas, L. M., Fontana, C. R., & Valente, V. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2019-0066 · Cited by 32
Decoding the Role of CD271 in Melanoma
Vidal, A., & Redmer, T. (2020) · Cancers · doi:10.3390/cancers12092460 · Cited by 42
BRCA1 is a new MITF target gene
Beuret, L., Ohanna, M., Strub, T., Allégra, M., Davidson, I., Bertolotto, C., & Ballotti, R. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00862.x · Cited by 31
Omaga, C. A., Fleming, A. M., & Burrows, C. J. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00226 · Cited by 31
Liu, T., Jin, L., Chen, M., Zheng, Z., Lü, W., Fan, W., Li, L., Zheng, F., Zhu, Q., Qiu, H., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101197 · Cited by 31
Caporali, S., Alvino, E., Levati, L., Esposito, A. I., Ciomei, M., Brasca, M. G., Bufalo, D. D., Desideri, M., Bonmassar, E., Pfeffer, U., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.004 · Cited by 27
Jirásková, K., Hughes, D. J., Brezina, S., Gumpenberger, T., Veškrňová, V., Büchler, T., Schneiderová, M., Levý, M., Liška, V., Vodenková, S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010097 · Cited by 25
An autoinhibitory role for the GRF zinc finger domain of DNA glycosylase NEIL3
Rodriguez, A. A., Wojtaszek, J. L., Greer, B. H., Haldar, T., Gates, K. S., Williams, R. S., & Eichman, B. F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015541 · Cited by 26
NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
Zhao, C., Liu, J., Zhou, H., Qian, X., Sun, H., Chen, X., Zheng, M., Bian, T., Liu, L., Liu, Y., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01938-4 · Cited by 26
Identification of DNA repair gene Ercc1 as a novel target in melanoma
Song, L., Ritchie, A., McNeil, E. M., Li, W., & Melton, D. W. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00882.x · Cited by 29
Ramakodi, M. P., Devarajan, K., Blackman, E. L., Gibbs, D. Y., Luce, D., Deloumeaux, J., Duflo, S. M., Liu, J., Mehra, R., Kulathinal, R. J., et al. (2016) · Cancer · doi:10.1002/cncr.30457 · Cited by 26
Figl, A., Scherer, D., Nagore, E., Bermejo, J. L., Dickes, E., Thirumaran, R. K., Gast, A., Hemminki, K., Kumar, R., & Schadendorf, D. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.011 · Cited by 26
Alvino, E., Passarelli, F., Cannavò, E., Fortes, C., Mastroeni, S., Caporali, S., Jiricny, J., Cappellini, G. C. A., Scoppola, A., Marchetti, P., et al. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcpcx2d9yulbblg · Cited by 31
DNA repair and replication proteins as prognostic markers in melanoma
Song, L., Robson, T., Doig, T. N., Brenn, T., Mathers, M. E., Brown, E. R., Doherty, V. R., Bartlett, J. M. S., Anderson, N., & Melton, D. W. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04362.x · Cited by 25
Methods of detection of circulating melanoma cells: A comparative overview
Nezos, A., Msaouel, P., Pissimissis, N., Lembessis, P., Sourla, A., Armakolas, A., Gogas, H. J., Stratigos, A., Katsambas, A., & Koutsilieris, M. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.10.002 · Cited by 28
Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression
Blacklock, K. B., Birand, Z., Selmic, L. E., Nelissen, P., Murphy, S., Blackwood, L., Bass, J., McKay, J., Fox, R. I., Beaver, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42839-x · Cited by 29
Confronting Melanoma Radioresistance: Mechanisms and Therapeutic Strategies
Gorodetska, I., Schulz, A., Behre, G., & Dubrovska, A. (2025) · Cancers · doi:10.3390/cancers17162648 · Cited by 26
Trappetti, V., Potez, M., Fernández-Palomo, C., Volarević, V., Shintani, N., Pellicioli, P., Ernst, A., Haberthür, D., Fazzari, J., Krisch, M. H., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.06.090 · Cited by 24
Evaluation of apoptotic effect of cyclic imide derivatives on murine B16F10 melanoma cells
Machado, K. E., de Oliveira, K. N., Bubniak, L. D. S., Licínio, M. A., Nunes, R. J., & Santos‐Silva, M. C. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.09.008 · Cited by 24
Mechanisms of chromosomal instability in melanoma
Kaufmann, W. K., Carson, C. C., Omolo, B., Filgo, A. J., Sambade, M. J., Simpson, D. A., Shields, J. M., Ibrahim, J. G., & Thomas, N. E. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21859 · Cited by 32
Mandal, P., Saha, S. S., Sen, S., Bhattacharya, A., Bhattacharya, N. P., Bucha, S., Sinha, M., Chowdhury, R. R., Mondal, N. R., Chakravarty, B., et al. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0154-x · Cited by 23
Sasaki, M., Miyoshi, N., Fujino, S., Saso, K., Ogino, T., Takahashi, H., Uemura, M., Yamamoto, H., Matsuda, C., Yasui, M., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.006 · Cited by 25
Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration
Higgs, E. F., Bao, R., Hatogai, K., & Gajewski, T. F. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004797 · Cited by 23
Hatch, S. B., Swift, L. P., Caporali, S., Carter, R., Hill, E. J., MacGregor, T. P., D’Atri, S., Middleton, M. R., McHugh, P. J., & Sharma, R. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28454 · Cited by 23
Evelyn, C. R., Lisabeth, E. M., Wade, S. M., Haak, A. J., Johnson, C. N., Lawlor, E. R., & Neubig, R. R. (2016) · Microarrays · doi:10.3390/microarrays5020013 · Cited by 25
Chang, H., Lee, C., Chen, Y., Huang, C., Yu, C., Lin, V. C.-H., Geng, J., Lu, T., Huang, S., & Bao, B. (2022) · Cancers · doi:10.3390/cancers14010223 · Cited by 24
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability
Berico, P., Nogaret, M., Cigrang, M., Lallement, A., Vand‐Rajabpour, F., Flores-Yanke, A., Gambi, G., Davidson, G., Seno, L., Obid, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113363 · Cited by 22
An appraisal of RECQ1 expression in cancer progression
Sharma, S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00426 · Cited by 21
Marignac, V. L. M., Rodrigue, A., Davidson, D. L., Couillard, M., Al-Moustafa, A.-E., Abramovitz, M., Foulkes, W. D., Masson, J., & Aloyz, R. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016394 · Cited by 23
Pagano, P. C., Tran, L. M., Bendris, N., O’Byrne, S. N., Tse, H. T. K., Sharma, S., Hoech, J. W., Park, S. J., Liclican, E. L., Jing, Z., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0335 · Cited by 22
Aldersley, J., Lorenz, D. R., Mouw, K. W., D’Andrea, A. D., & Gabuzda, D. H. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0884 · Cited by 21
Melanopsin (Opn4) is an oncogene in cutaneous melanoma
de Assis, L. V. M., Lacerda, J. T., Moraes, M. N., Domínguez-Amorocho, O. A., Kinker, G. S., Mendes, D., Silva, M. M., Menck, C. F. M., Câmara, N. O. S., & Castrucci, A. M. D. L. (2022) · Communications Biology · doi:10.1038/s42003-022-03425-6 · Cited by 21
Ireland, A., Millward, M., Pearce, R., Lee, M., & Ziman, M. R. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9368-2 · Cited by 24
Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52
Chen, C., Huang, J.-S., Wang, T., Kuo, C.-H., Wang, C.-J., Wang, S., & Leu, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122655 · Cited by 24
A novel signature based on microvascular invasion predicts the recurrence of HCC
Du, B., Wang, F., Jarad, B., Wang, Z., & Zhang, Y. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02432-7 · Cited by 21
Rajagopalan, P., Patel, K., Jain, A., Nanjappa, V., Datta, K. K., Subbannayya, T., Mangalaparthi, K. K., Kumari, A., Manoharan, M., Coral, K., et al. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1470724 · Cited by 21
Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells
Xiong, W., Liao, Y., Qin, J., Li, W., & Tang, Z. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.04.004 · Cited by 22
MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth
Wilms, C., Kroeger, C. M., Hainzl, A., Banik, I., Bruno, C., Krikki, I., Farsam, V., Wlaschek, M., & Gatzka, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18617 · Cited by 20
Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer
Azenha, D., Hernández-Pérez, S., Martín, Y., Viegas, M. S., Martins, A., Lopes, M. C., Lam, E. W. ‐., Freire, R., & Martins, T. (2020) · Cancers · doi:10.3390/cancers12092396 · Cited by 20
Adenoviral Vector Driven by a Minimal Rad51 Promoter Is Selective for p53-Deficient Tumor Cells
Fong, V., Osterbur, M. L., Capella, C., Kim, Y.-E., Hine, C., Gorbunova, V. A., Seluanov, A., & Dewhurst, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028714 · Cited by 23
Pachkowski, B. F., Guyton, K. Z., & Sonawane, B. R. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.05.003 · Cited by 22
Predicting Response to Chemotherapy With Early-Stage Lung Cancer
Rosell, R., Tarón, M., Massutí, B., Mederos, N., Magrí, I., Santarpía, M., & Sánchez, J. M. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182091fa3 · Cited by 19
CHK2 Promotes Anoikis and is Associated with the Progression of Papillary Thyroid Cancer
Zhao, W., Chen, S., Hou, X., Chen, G., & Zhao, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487724 · Cited by 20
Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
Maresca, L., Stecca, B. A., & Carrassa, L. (2022) · Cells · doi:10.3390/cells11091466 · Cited by 17
The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models
Vicente, C., Stirparo, R., Demeyer, S., de Bock, C. E., Gielen, O., Atkins, M., Yan, J., Halder, G. A., Hassan, B. A., & Cools, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0650-0 · Cited by 17
Zhuang, L., Zhang, Y., Meng, Z., & Yang, Z. (2020) · Cancer Control · doi:10.1177/1073274820977149 · Cited by 15
Kaempferol inhibits non-homologous end joining repair via regulating Ku80 stability in glioma cancer
Chen, M., Zhao, E., Li, M., Xu, M., Hao, S., Gao, Y., Wu, X., Li, X., Yu, Y., Yu, Z., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154876 · Cited by 15
An Attempt at a Molecular Prediction of Metastasis in Patients with Primary Cutaneous Melanoma
Gschaider, M., Neumann, F., Peters, B., Lenz, F., Cibena, M., Goiser, M., Wolf, I. H., Wenzel, J., Mauch, C., Schreiner, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049865 · Cited by 15
Santonocito, C., Scapaticci, M., Penitente, R., Paradisi, A., Capizzi, R., Silveri, S. L., Ficarra, S., Landi, F., Zuppi, C., & Capoluongo, E. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.06.013 · Cited by 15
Song, L., McNeil, E. M., Ritchie, A., Astell, K. R., Gourley, C., & Melton, D. W. (2017) · BMC Cancer · doi:10.1186/s12885-017-3864-6 · Cited by 21
Synthesis and Characterization of Silver Nanoparticles Against Two Stored Commodity Insect Pests
Abbas, F., Tahir, M. U., Farman, M., Mumtaz, M., Aslam, M. R., Mughal, S. S., Ayub, A. R., Shafiq, S., Ashraf, F., Ullah, H., et al. (2020) · International Journal of Scientific and Research Publications · doi:10.29322/ijsrp.10.04.2020.p10002 · Cited by 14
Cheema, M. S., Good, K., Kim, B., Soufari, H., O’Sullivan, C., Freeman, M. E., Stefanelli, G., Rivera-Casas, C., Zengeler, K. E., Kennedy, A. J., et al. (2020) · Cells · doi:10.3390/cells9051167 · Cited by 15
Altération de la réparation de l’ADN et cancer
Rancoule, C., Vallard, A., Guy, J., Espenel, S., Sauvaigo, S., Rodriguez‐Lafrasse, C., & Magné, N. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.09.006 · Cited by 16
The classification of melanocytic gene signatures
Hu, M., Coleman, S. S., Judson‐Torres, R. L., & Tan, A. C. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13189 · Cited by 12
Identification of potential therapeutic targets for melanoma using gene expression analysis
Quan, L., Shi, J., TIAN, Y., ZHANG, Q., ZHANG, Y., ZHANG, Y., Hui, Q., & Tao, K. X. (2015) · Neoplasma · doi:10.4149/neo_2015_087 · Cited by 13
Bacolod, M. D., & Barany, F. (2021) · Cancers · doi:10.3390/cancers13205158 · Cited by 14
Expression Profiling of Melanoma Cell Lines: In Search of A Progression-Related Molecular Signature
van den Oord, J. J., Sarasin, A. R., Winnepenninckx, V. J. L., & Spatz, A. (2007) · Future Oncology · doi:10.2217/14796694.3.6.609 · Cited by 13
Self-citationKIM, Y. S., KIM, Y., CHOI, J. W., Oh, H., & Lee, J. H. (2016) · Neoplasma · doi:10.4149/neo_2016_418 · Cited by 13
Serafim, R. B., Cardoso, C. C., Storti, C. B., da Silva, P., Qi, H., Parasuram, R., Navegante, G., Peron, J. P. S., Silva, W. A., Espreáfico, E. M., et al. (2024) · Oncogene · doi:10.1038/s41388-024-02937-1 · Cited by 13
Aliyaskarova, U., Baiken, Y., Renaud, F., Couvé, S., Kisselev, A. F., Saparbaev, M. K., & Groisman, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-32186-3 · Cited by 12
Zhao, Y., Feng, H., Yan, W., & Yu, Q. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.833829 · Cited by 11
Emmert, S., & Kraemer, K. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.72 · Cited by 11
Vasconcelos, R. O., Serini, S., Votto, A. P. D. S., Trindade, G. S., Fanali, C., Sgambato, A., & Calviello, G. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000564 · Cited by 11
Romanowicz, H., Strapagiel, D., Słomka, M., Sobalska‐Kwapis, M., Kępka, E., Siewierska-Górska, A., Zadrożny, M., Bieńkiewicz, J., & Smolarz, B. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0441-2 · Cited by 10
Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma
Wu, D., Zhang, G., Ma, J., Wu, H.-F., Xiong, J., Huang, X., Tian, Y., Deng, T., Han, X., Sun, X., et al. (2021) · Journal of Oncology · doi:10.1155/2021/1301671 · Cited by 10
Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants
Fraile‐Bethencourt, E., Valenzuela‐Palomo, A., Díez‐Gómez, B., Infante, M., Durán, M., Marcos, G., Lastra, E., Gómez‐Barrero, S., & Velasco, E. A. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4826-7 · Cited by 11
Groarke, E. M., Calado, R. T., & Liu, J. M. (2022) · Seminars in Hematology · doi:10.1053/j.seminhematol.2022.01.003 · Cited by 11
Cancer stem cells in cutaneous melanoma
Wouters, J., Vankelecom, H. E. J., & van den Oord, J. (2009) · Expert Review of Dermatology · doi:10.1586/edm.09.17 · Cited by 11
Bao, Y., Feng, H., Zhao, F., Zhang, L., Xu, S., Zhang, C., Zhao, C., & Qin, G. (2020) · Neoplasma · doi:10.4149/neo_2020_200511n516 · Cited by 9
DNA with damage in both strands as affinity probes and nucleotide excision repair substrates
Lukyanchikova, N. V., Petruseva, I. O., Evdokimov, A. N., Silnikov, V. N., & Lavrik, O. I. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916030093 · Cited by 9
Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors
Kroeger, C. M., Roesler, R., Wiese, S., Hainzl, A., & Gatzka, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113762 · Cited by 9
Liccardo, R., Nolano, A., Lambiase, M., Ragione, C. D., Rosa, M. D., Izzo, P., & Duraturo, F. (2020) · Biomedicines · doi:10.3390/biomedicines8060167 · Cited by 9
Janik, M., Szwed, S., Grzmil, P., Kaczmarek, R., Czerwiński, M., & Hoja-Łukowicz, D. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.05.007 · Cited by 9
Targeting Genome Stability in Melanoma—A New Approach to an Old Field
Osrodek, M., & Woźniak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073485 · Cited by 12
Smolarz, B., Makowska, M., Samulak, D., Michalska, M., & Romanowicz, H. (2014) · Familial Cancer · doi:10.1007/s10689-014-9746-z · Cited by 8
5’‐Phosphorylation Increases the Efficacy of Nucleoside Inhibitors of the DNA Repair Enzyme SNM1A
Berney, M., Manoj, M. T., Fay, E. M., & McGouran, J. F. (2021) · ChemMedChem · doi:10.1002/cmdc.202100603 · Cited by 8
Wang, H., Chan, L., Wu, C., Chang, S., Moi, S., Luo, C., & Pan, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052402 · Cited by 8
Molecular pathology of cutaneous melanoma
van Kempen, L. C. L. T., Redpath, M., Robert, C., & Spatz, A. (2014) · Melanoma Management · doi:10.2217/mmt.14.23 · Cited by 10
Self-citationEffects of Rad51 on Survival of A549 Cells
Yu, S.-S., Tu, Y., Xu, L., Tao, X.-Q., Xu, S., Wang, S., Xiong, Y., & Mei, J. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.1.175 · Cited by 7
The HGF/SF Mouse Model of UV-Induced Melanoma as an In Vivo Sensor for Metastasis-Regulating Gene
Leonard, M. K., Pamidimukkala, N., Puts, G. S., Snyder, D. E., Slominski, A. T., & Kaetzel, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081647 · Cited by 8
Li, L., Zou, B.-J., Zhao, J.-Z., Liang, J.-B., She, Z.-Y., Zhou, W., Lin, S.-X., Tian, L., Wen-ji, L., & He, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.961274 · Cited by 8
Melanocytic Neoplasms I: Molecular Diagnosis
Gerami, P., Gammon, B., & Murphy, M. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-171-4_5 · Cited by 8
Age-Related Oxidative Changes in Primary Porcine Fibroblasts Expressing Mutated Huntingtin
Šmatlíková, P., Askeland, G., Vaškovičová, M., Klíma, J., Motlík, J., Eide, L., & Ellederová, Z. (2019) · Neurodegenerative Diseases · doi:10.1159/000500091 · Cited by 7
Tourneau, C. L., Delord, J., Kotecki, N., Borcoman, É., Gomez‐Roca, C., Hescot, S., Jungels, C., Vincent‐Salomon, A., Cockenpot, V., Eberst, L., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01028-8 · Cited by 9
Tarhini, A. A., Floros, T., Lin, H., Lin, Y. Z., Rahman, Z., Ashraf, M., Vallabhaneni, P., Sander, C., Rao, U. N. M., Panelli, M. C., et al. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000383 · Cited by 7
Arnold, M. R., Chen, S., & Unni, V. K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1554059 · Cited by 6
MRE11A: a novel negative regulator of human DNA mismatch repair
Du, D., Yang, Y., Zhang, Y., Wang, G., Chen, L., Guan, X., Rasmussen, L. J., & Liu, D. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00547-z · Cited by 7
Puts, G. S., Jarrett, S. G., Leonard, M. K., Matsangos, N., Snyder, D. E., Wang, Y., Vincent, R., Portney, B. A., Abbotts, R., McLaughlin, L. J., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165896 · Cited by 6
Li, J., Xie, Y., Wang, X., Jiang, C., Yuan, X., Zhang, A., Yang, L., Liu, C., Zou, H., Li, F., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12077 · Cited by 6
Correction: Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration
Rákosy, Z., Ecsedi, S., Tóth, R., Vízkeleti, L., Hernández‐Vargas, H., Lázár, V., Emri, G., Szatmári, I., Herceg, Z., Ádány, R., et al. (2013) · PLoS ONE · doi:10.1371/annotation/27b2c2c3-3b09-4c0c-9e20-8dc0226404f3 · Cited by 6
Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade
Alblihy, A., Ali, R., Algethami, M., Ritchie, A., Shoqafi, A., Alqahtani, S., Mesquita, K. A., Toss, M. S., Ordóñez‐Morán, P., Jeyapalan, J. N., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310966 · Cited by 6
Yang, J., Zeng, X., Pei, J., Zhou, S., Liu, Q., Zhang, Y., Yang, Y., Li, R., Zhou, F. G., & Deng, Y. (2025) · Medical Oncology · doi:10.1007/s12032-025-02601-y · Cited by 5
Sun, X., & Liu, P. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1073941 · Cited by 5
NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation
Zhang, M., Jiang, Y., Wang, J., Yue, Y., Liu, W., Wang, L., Li, Y., Wang, W., Cai, H., Yang, Z., et al. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103604 · Cited by 5
Gąsior‐Perczak, D., Kowalik, A., Kopczyński, J., Macek, P., Niemyska, K., Walczyk, A., Gruszczyński, K., Siołek, M., Dróżdż, T., Kosowski, M., et al. (2024) · Cancers · doi:10.3390/cancers16040815 · Cited by 8
Molina-García, M., Rojas‐Lechuga, M. J., Torres, T., Bagué, J., Mateu, J., Langdon, C., Lop, J., de Souza, V. G., Alós, L., López‐Chacon, M., et al. (2024) · Cancers · doi:10.3390/cancers16244172 · Cited by 6
Metadata
- Authors
- Kauffmann, A., Rosselli, F., Lazar, V, Winnepenninckx, V, Mansuet-Lupo, A., Dessen, P., van den Oord, J. J., Spatz, A., & Sarasin, A.
- Affiliations
- Université Paris-Sud (FR)
- Institut Gustave Roussy (FR)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Sarasin, A
- Venue
- Oncogene
- Published
- 2007-09-24
- Volume
- 27
- Issue
- 5
- Pages
- 565-573
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2013996063
- Cited by
- 274
- References
- 35
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 23 · 2020: 24 · 2019: 7 · 2018: 16 · 2017: 22 · 2016: 15 · 2015: 17 · 2014: 16 · 2013: 12 · 2012: 15
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Université Paris Diderot
- Institut Gustave-Roussy
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- melanoma, metastasis, DNA repair pathways, DNA replication, gene expression signatures, prognostic factors, genetic stability, chemoresistance, radiotherapy resistance
- MeSH terms
- Cell Transformation, Neoplastic, DNA Repair, Humans, Melanoma, Skin Neoplasms, Gene Expression Regulation, Neoplastic, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.